Nanalysis Scientific Corp. (TSXV:NSCI)
Canada · Delayed Price · Currency is CAD 0.1250
0.00 (0.00%)
At close: Jul 31, 2026
Nanalysis Scientific Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5.63 | -5.66 | -13.61 | -16.78 | -9.92 | -1.77 |
Depreciation & Amortization | 3.39 | 3.43 | 4.63 | 4.67 | 4.65 | 2.57 |
Stock-Based Compensation | 0.34 | 0.4 | 1.03 | 1.05 | 1.56 | 0.59 |
Other Adjustments | 0.24 | 4.28 | 12.66 | 3.09 | -0.59 | -0.11 |
Change in Receivables | - | 2.74 | -1.52 | -1.84 | -0.88 | -3.41 |
Changes in Inventories | - | 0.74 | 1.42 | 0.82 | -3.08 | -0.63 |
Changes in Accounts Payable | - | -0.55 | 0.18 | -0.33 | 0.86 | 1.8 |
Changes in Other Operating Activities | 0.13 | 0.8 | 1.07 | -4.49 | -5.24 | -2.71 |
Operating Cash Flow | 0.64 | 3.45 | 3.26 | -11.19 | -8.55 | -1.2 |
Operating Cash Flow Growth | -85.66% | 5.79% | - | - | - | - |
Capital Expenditures | -0.27 | -0.28 | -0.06 | -0.73 | -2.13 | -0.6 |
Sale of Property, Plant & Equipment | 0.12 | 0.11 | 0.17 | 0.05 | 0.08 | 0 |
Purchases of Intangible Assets | -1.24 | -1.6 | -1.8 | -3.86 | -5.07 | -2.41 |
Cash Acquisitions | - | - | - | - | -0.61 | -0.35 |
Other Investing Activities | - | - | - | -1.51 | -3.77 | - |
Investing Cash Flow | -1.38 | -1.78 | -1.69 | -6.06 | -11.5 | -3.35 |
Short-Term Debt Issued | - | 0 | -0.11 | 6.06 | 2.54 | - |
Short-Term Debt Repaid | 0.62 | - | - | -5.7 | -2.53 | - |
Net Short-Term Debt Issued (Repaid) | 0.62 | 0 | -0.11 | 0.36 | 0.01 | - |
Long-Term Debt Issued | 4.82 | 4.04 | 4.34 | 16.21 | 15.05 | 11.77 |
Long-Term Debt Repaid | -3.48 | -2.16 | -3.26 | -0.23 | -1.25 | -0.2 |
Net Long-Term Debt Issued (Repaid) | 1.34 | 1.89 | 1.08 | 15.98 | 13.79 | 11.57 |
Issuance of Common Stock | - | - | - | 0.03 | 0.27 | 0.44 |
Net Common Stock Issued (Repurchased) | - | - | - | 0.03 | 0.27 | 0.44 |
Other Financing Activities | -1.61 | -1.78 | -1.83 | -1.89 | -0.91 | -0.22 |
Financing Cash Flow | 0.76 | 0.11 | -0.96 | 14.48 | 13.16 | 11.79 |
Net Cash Flow | 0.02 | 1.78 | 0.62 | -2.77 | -6.88 | 7.25 |
Free Cash Flow | 0.38 | 3.17 | 3.21 | -11.92 | -10.67 | -1.79 |
Free Cash Flow Growth | -91.47% | -1.15% | - | - | - | - |
FCF Margin | 0.94% | 7.90% | 7.05% | -41.87% | -43.00% | -11.18% |
Free Cash Flow Per Share | 0.00 | 0.03 | 0.03 | -0.12 | -0.12 | -0.03 |
Levered Free Cash Flow | -0.42 | 0.37 | -5.39 | -0.51 | -1.05 | 10.23 |
Unlevered Free Cash Flow | -0.35 | 0.36 | -3.5 | -13.55 | -14.62 | -1.3 |